Amiodarone hydrochloride

Amiodarone hydrochloride is an anti-anginal agent and a class III antiarrhythmic drug that inhibits potassium channels (including wild-type hERG channels and their tail currents, with an IC₅₀ of approximately 45 nM) as well as voltage-gated sodium channels. This leads to prolonged action potential duration in ventricular and atrial myocytes, resulting in reduced heart rate and vascular resistance. It activates ERK1/2 and p38 MAPK signaling pathways in fibroblasts, promoting cell proliferation and myofibroblast differentiation. Amiodarone hydrochloride is widely used in the study of supraventricular and ventricular arrhythmias and can also be used to establish pulmonary fibrosis animal models.

Amiodarone-d10 Hydrochloride is a deuterated compound of Amiodarone Hydrochloride. Amiodarone Hydrochloride has a CAS number of 19774-82-4. Amiodarone hydrochloride is an antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.

Amiodarone-d4 HCl is a deuterated compound of Amiodarone HCl. Amiodarone HCl has a CAS number of 19774-82-4. Amiodarone hydrochloride is an antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.

Amiodarone is an antiarrhythmic compound that inhibits ATP-sensitive potassium channels (IC₅₀ = 19.1 μM) and can induce pulmonary toxicity. It has shown some antiviral activity in diseases caused by SARS-CoV-2 and is commonly used to establish animal models of pulmonary fibrosis.